Opin vísindi

Hematopoietic Stem Cell Transplantation Resolves the Immune Deficit Associated with STAT3-Dominant-Negative Hyper-IgE Syndrome

Hematopoietic Stem Cell Transplantation Resolves the Immune Deficit Associated with STAT3-Dominant-Negative Hyper-IgE Syndrome


Title: Hematopoietic Stem Cell Transplantation Resolves the Immune Deficit Associated with STAT3-Dominant-Negative Hyper-IgE Syndrome
Author: Harrison, Stephanie C.
Tsilifis, Christo
Slatter, Mary A.
Nademi, Zohreh
Worth, Austen
Veys, Paul
Ponsford, Mark J.
Jolles, Stephen
Al-Herz, Waleed
Flood, Terence
... 10 more authors Show all authors
Date: 2021-02-01
Language: English
Scope: 10
Department: Faculty of Medicine
Women's and Childrens's Services
Series: Journal of Clinical Immunology; 41(5)
ISSN: 0271-9142
DOI: https://doi.org/10.1007/s10875-021-00971-2
Subject: Stofnfrumuígræðsla; Autosomal dominant hyper IgE syndrome; dominant-negative STAT3 mutations; hematopoietic stem cell transplantation; Job syndrome; STAT3-HIES T17 cells; Immunology and Allergy; Immunology
URI: https://hdl.handle.net/20.500.11815/2916

Show full item record

Citation:

Harrison , S C , Tsilifis , C , Slatter , M A , Nademi , Z , Worth , A , Veys , P , Ponsford , M J , Jolles , S , Al-Herz , W , Flood , T , Cant , A J , Doffinger , R , Barcenas-Morales , G , Carpenter , B , Hough , R , Haraldsson , Á , Heimall , J , Grimbacher , B , Abinun , M & Gennery , A R 2021 , ' Hematopoietic Stem Cell Transplantation Resolves the Immune Deficit Associated with STAT3-Dominant-Negative Hyper-IgE Syndrome ' , Journal of Clinical Immunology , vol. 41 , no. 5 , pp. 934-943 . https://doi.org/10.1007/s10875-021-00971-2

Abstract:

Autosomal dominant hyper-IgE syndrome caused by dominant-negative loss-of-function mutations in signal transducer and activator of transcription factor 3 (STAT3) (STAT3-HIES) is a rare primary immunodeficiency with multisystem pathology. The quality of life in patients with STAT3-HIES is determined by not only the progressive, life-limiting pulmonary disease, but also significant skin disease including recurrent infections and abscesses requiring surgery. Our early report indicated that hematopoietic stem cell transplantation might not be effective in patients with STAT3-HIES, although a few subsequent reports have reported successful outcomes. We update on progress of our patient now with over 18 years of follow-up and report on an additional seven cases, all of whom have survived despite demonstrating significant disease-related pathology prior to transplant. We conclude that effective cure of the immunological aspects of the disease and stabilization of even severe lung involvement may be achieved by allogeneic hematopoietic stem cell transplantation. Recurrent skin infections and abscesses may be abolished. Donor TH17 cells may produce comparable levels of IL17A to healthy controls. The future challenge will be to determine which patients should best be offered this treatment and at what point in their disease history.

Description:

CT is supported by The Job Research Foundation. MJP is supported by the Welsh Clinical Academic Training (WCAT) programme and is a participant in the NIH Graduate Partnership Program. BG receives support through the Deutsche Forschungsgemeinschaft (DFG) SFB1160/2_B5, under Germany’s Excellence Strategy (CIBSS—EXC-2189—Project ID 390939984, and RESIST—EXC 2155—Project ID 390874280); through the E-rare program of the EU, managed by the DFG, grant code GR1617/14-1/iPAD, and through the “Netzwerke Seltener Erkrankungen” of the German Ministry of Education and Research (BMBF), grant code: GAIN_ 01GM1910A. This work was supported in part by the Center for Chronic Immunodeficiency (CCI), Freiburg Center for Rare Diseases (FZSE). Publisher Copyright: © 2021, The Author(s).

Files in this item

This item appears in the following Collection(s)